South Korea cuts first-quarter COVID-19 vaccination plan, restricts use of AstraZeneca shot

South Korea said on Monday it will not use AstraZeneca’s coronavirus vaccine on people aged 65 and older, reversing an earlier decision, and scaled back initial vaccination targets due to delayed shipments from global vaccine-sharing scheme COVAX. South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000. The decision is largely due to adjustments in the supply timetable of the 2.6 million doses of AstraZeneca vaccine from COVAX, the Korea Disease Control and Prevention Agency (KDCA) said